Rondo Therapeutics
USEntry
2022
Hold
4yr
Status
Active
Who owns Rondo Therapeutics?
Rondo Therapeutics is currently owned by SV Health Managers through SV7 Impact Medicine Fund (2019 vintage), since 2022. Across its history, Rondo Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-16
Most recent investor
SV Health ManagersSV7 Impact Medicine Fund · 2019 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2022 · present
Novo HoldingsActive
2022 · present(4yr) · Novo Holdings Venture Investments · 1999 · VC
SV Health ManagersActive
2022 · present(4yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
More from SV7 Impact Medicine Fund
Other portfolio companies in the same fund.
UK
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Rondo Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Rondo Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Rondo Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue